Industrial Biotechnology Congress
Mikael Bjerg Caspersen
Novozymes Biopharma, UK
Mikael Bjerg Caspersen has completed his PhD from The Technological University of Denmark and did Post-doctoral studies at The University of Copenhagen. He has a background working in the Analytical service industry from Ciphergen Biosystems and in the CMO industry from working at CMC Biologics. He is working at Novozymes Biopharma with the development and implementation of albumin based technologies for formulation and half-life extension.
Abstract : Veltis®: Innovative albumin based technology for half-life extension and optimization of biotherapeutics
Notice: Undefined index: tittle in /var/www/universal_code/speaker-details.php on line 312